| Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease S Kripalani, J Risser, ME Gatti, TA Jacobson Value in Health 12 (1), 118-123, 2009 | 460 | 2009 |
| Current landscape of immunotherapy in breast cancer: a review S Adams, ME Gatti-Mays, K Kalinsky, LA Korde, E Sharon, ... JAMA oncology 5 (8), 1205-1214, 2019 | 324 | 2019 |
| Relationships between beliefs about medications and adherence ME Gatti, KL Jacobson, JA Gazmararian, B Schmotzer, S Kripalani American Journal of Health-System Pharmacy 66 (7), 657-664, 2009 | 277 | 2009 |
| Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors M Bilusic, CR Heery, JM Collins, RN Donahue, C Palena, RA Madan, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 191 | 2019 |
| Association of age, health literacy, and medication management strategies with cardiovascular medication adherence S Kripalani, ME Gatti, TA Jacobson Patient education and counseling 81 (2), 177-181, 2010 | 175 | 2010 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| If we build it they will come: targeting the immune response to breast cancer ME Gatti-Mays, JM Balko, SR Gameiro, HD Bear, S Prabhakaran, J Fukui, ... NPJ breast cancer 5 (1), 37, 2019 | 167 | 2019 |
| Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations ME Gatti-Mays, JM Redman, JM Collins, M Bilusic Human vaccines & immunotherapeutics 13 (11), 2561-2574, 2017 | 112 | 2017 |
| Effect of incision choice on outcomes in primary breast augmentation JM Jacobson, ME Gatti, AD Schaffner, LM Hill, SL Spear Aesthetic surgery journal 32 (4), 456-462, 2012 | 110 | 2012 |
| Occupational injury in plastic surgeons AC Capone, PM Parikh, ME Gatti, BJ Davidson, SP Davison Plastic and reconstructive surgery 125 (5), 1555-1561, 2010 | 108 | 2010 |
| A head-to-head comparison of quality of life and aesthetic outcomes following immediate, staged-immediate, and delayed oncoplastic reduction mammaplasty [outcomes article] KM Patel, CM Hannan, ME Gatti, MY Nahabedian Plastic and reconstructive surgery 127 (6), 2167-2175, 2011 | 97 | 2011 |
| A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women’s cancers with … AS Zimmer, E Nichols, A Cimino-Mathews, C Peer, L Cao, MJ Lee, ... Journal for immunotherapy of cancer 7, 1-8, 2019 | 95 | 2019 |
| Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies J Strauss, ME Gatti-Mays, BC Cho, A Hill, S Salas, E McClay, JM Redman, ... Journal for immunotherapy of cancer 8 (2), 2020 | 89 | 2020 |
| Indications and outcomes following complex abdominal reconstruction with component separation combined with porcine acellular dermal matrix reinforcement KM Patel, MY Nahabedian, M Gatti, P Bhanot Annals of plastic surgery 69 (4), 394-398, 2012 | 78 | 2012 |
| Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer DB Page, H Bear, S Prabhakaran, ME Gatti-Mays, A Thomas, E Cobain, ... NPJ breast cancer 5 (1), 34, 2019 | 71 | 2019 |
| Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer LA Emens, S Adams, A Cimino-Mathews, ML Disis, ME Gatti-Mays, AY Ho, ... Journal for immunotherapy of cancer 9 (8), 2021 | 67 | 2021 |
| Management of massive mastectomy skin flap necrosis following autologous breast reconstruction KM Patel, LM Hill, ME Gatti, MY Nahabedian Annals of plastic surgery 69 (2), 139-144, 2012 | 62 | 2012 |
| A phase I dose-escalation trial of BN-CV301, a recombinant poxviral vaccine targeting MUC1 and CEA with costimulatory molecules ME Gatti-Mays, J Strauss, RN Donahue, C Palena, J Del Rivero, ... Clinical Cancer Research 25 (16), 4933-4944, 2019 | 51 | 2019 |
| Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy Y Wang, KCC Johnson, ME Gatti-Mays, Z Li Journal of hematology & oncology 15 (1), 118, 2022 | 48 | 2022 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
James L. GulleyNational Cancer InstituteVerified email at mail.nih.gov
